Article(id=1327671857307824410, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.11.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1658419200000, receivedDateStr=2022-07-22, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471237732, onlineDateStr=2026-11-12, pubDate=1668009600000, pubDateStr=2022-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471237732, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471237732, creator=13701087609, updateTime=1794471237732, updator=13701087609, issue=Issue{id=1327671856833868058, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='11', pageStart='1529', pageEnd='1670', issueExtLink='null', onlineDate='null', pubDate='1668009600000', pubDateStr='2022-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471237619, creator='13701087609', updateTime=1794472094917, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327675453114004391, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327675453114004392, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1529, endPage=1538, ext={EN=ArticleExt(id=1327671857467207963, articleId=1327671857307824410, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=The Role and Consideration of Accelerated Approval Process in Pediatric Drug Registration System, columnId=null, journalTitle=Chinese Journal of Pharmaceuticals, columnName=null, runingTitle=null, highlight=null, articleAbstract=

Difficulty in research and development(R&D) of pediatric drugs is a global problem. The high difficulty of R&D, high costs and long cycle of pediatric drugs, as well as the low market returns compared with the adult medicines because of the short medication cycle, aggravate the inactive R&D situation of pediatric drugs. In order to encourage the R&D of pediatric drugs in China, various countries have adopted many measures to acclerate the R&D of pediatric drugs. This paper summarizes and analyzes the special policies and related technical guidelines issued by US, EU, Japan and China to accelerate the review and approval of pediatric drugs, which will serve as a referance for Chinese pediatric drugs developers and the follow-up government regulation and policy makers.

, authors=Lijia YUAN, Liqing WANG, Xiaoyan WANG, Ning ZHANG*, authorsList=Lijia YUAN, Liqing WANG, Xiaoyan WANG, Ning ZHANG, authorCompany=null, correspAuthors=Ning ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327671858490618141, articleId=1327671857307824410, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=药品加快上市程序在儿童用药注册体系中的作用与思考, columnId=1327671857534316828, journalTitle=中国医药工业杂志, columnName=本期主题:儿童药创新研发与科学监管, runingTitle=null, highlight=null, articleAbstract=

儿童用药研发困难是全世界面临的难题。由于儿童用药研发难度大、研发成本高、周期长,同时儿童用药服药周期较短,与成人用药的市场相比,市场回报较低,加剧了企业对儿童用药研发不活跃的状况。为了鼓励儿童用药研发,各个国家或地区通过诸多措施鼓励儿童用药的研发。文章对美、欧、日、中等国家及地区为加快儿童用药上市而制定的特殊政策、发布的相关技术指南进行了归纳、汇总并分析,为中国儿童用药研发者及后续的政府法规政策制定提供借鉴及参考。

, authors=袁利佳, 王丽卿, 汪小燕, 张宁*, authorsList=袁利佳, 王丽卿, 汪小燕, 张宁, authorCompany=null, correspAuthors=张宁, authorNote=

袁利佳(1981—),男,审评项目管理员,从事审评管理工作。

, correspAuthorsNote=
张宁(1976—),女,高级审评员,从事药品审评工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=4X/Cllko96D/B7qS3ToImg==, magXml=RUFzWyQ95f2KAgIc08qbKA==, pdfUrl=null, pdf=xsr95lp8AeuozdGMhJWA7g==, pdfFileSize=2153183, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=YpgBbdWoCP9XyX1Xrk5jWQ==, mapNumber=null, fund=null)}, authors=[Author(id=1327672011062620642, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672011146506725, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011062620642, language=EN, stringName=Lijia YUAN, firstName=Lijia, middleName=null, lastName=YUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672011213615590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011062620642, language=CN, stringName=袁利佳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

袁利佳(1981—),男,审评项目管理员,从事审评管理工作。

"}, bioImg=null, bioContent=

袁利佳(1981—),男,审评项目管理员,从事审评管理工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672011280724456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672012987806187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011280724456, language=EN, stringName=Liqing WANG, firstName=Liqing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672013067497964, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011280724456, language=CN, stringName=王丽卿, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672013147189742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672013243658736, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013147189742, language=EN, stringName=Xiaoyan WANG, firstName=Xiaoyan, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672013323350513, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013147189742, language=CN, stringName=汪小燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672013390459379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangning@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672013470151157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013390459379, language=EN, stringName=Ning ZHANG, firstName=Ning, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672013533065718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013390459379, language=CN, stringName=张宁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1327672013700837879, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, language=EN, orderNo=1, keyword=pediatric drug), Keyword(id=1327672013784723960, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, language=EN, orderNo=2, keyword=drug regisration), Keyword(id=1327672013860221433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, language=EN, orderNo=3, keyword=accelerated system), Keyword(id=1327672013944107514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, language=CN, orderNo=1, keyword=儿童用药), Keyword(id=1327672014019604987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, language=CN, orderNo=2, keyword=药品注册), Keyword(id=1327672014082519548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, language=CN, orderNo=3, keyword=加快程序)], refs=[Reference(id=1327672014225125885, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=国家统计局.第七次全国人口普查公报(第五号)—人口年龄构成情况[EB/OL].(2021-05-11)[2022-07-22].http://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202105/t20210511_1817200.html., articleTitle=null, refAbstract=null), Reference(id=1327672014300623358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=余明莲,杨悦.我国儿童用药可获得性的调查分析[J].解放军药学学报,2011,27(4):368-372., articleTitle=null, refAbstract=null), Reference(id=1327672014367732223, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=龚传欢,杨悦,田丽娟.儿科药物研发激励政策研究[J].中国新药杂志,2022,31(11):1042-1047., articleTitle=null, refAbstract=null), Reference(id=1327672014426452480, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=许淑红,张绮,张林琦,等.探讨我国儿童用药的发展现状及政策层面的思考[J].中国临床药理学杂志,2020,36(12):1760-1767., articleTitle=null, refAbstract=null), Reference(id=1327672014489367041, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Pediatric Research Equity Act | PREA [EB/OL].(2019-07-11)[2022-07-22].https://www.fda.gov/drugs/development-resources/pediatric-research-equity-act-prea., articleTitle=null, refAbstract=null), Reference(id=1327672014569058818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Best Pharmaceuticals for Children Act (BPCA) [EB/OL].(2018-09-25)[2022-07-22].https://www.fda.gov/drugs/development-resources/best-pharmaceuticals-children-act-bpca., articleTitle=null, refAbstract=null), Reference(id=1327672014644556291, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Pediatric study plans: content of and process for submitting initial pediatric study plans and amended initial pediatric study plans [EB/OL].(2020-08-03)[2022-07-22].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pediatric-study-plans-content-and-process-submitting-initial-pediatric-study-plans-and-amended., articleTitle=null, refAbstract=null), Reference(id=1327672014720053764, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Pediatric labeling changes [EB/OL].(2022-08-30)[2022-09-01].https://www.fda.gov/science-research/pediatrics/pediatric-labeling-changes., articleTitle=null, refAbstract=null), Reference(id=1327672014812328453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Food and Drug Administration Moderization Act of 1997[EB/OL].(1997-11-21)[2022-07-22].https://www.congress.gov/105/plaws/publ115/PLAW-105publ115.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672014871048710, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.List of drugs for which pediatric studies are needed[EB/OL].(2019-04-29)[2022-07-22].https://cacmap.fda.gov/drugs/development-resources/list-drugs-which-pediatric-studies-are-needed., articleTitle=null, refAbstract=null), Reference(id=1327672014942351879, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Office of pediatric therapeutics [EB/OL].(2021-10-25)[2022-07-22].https://www.fda.gov/about-fda/office-clinical-policy-and-programs/office-pediatric-therapeutics., articleTitle=null, refAbstract=null), Reference(id=1327672014996877832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Pediatric Advisory Committee [EB/OL].(2022-04-13)[2022-07-22].https://www.fda.gov/advisory-committees/committees-and-meeting-materials/pediatric-advisory-committee., articleTitle=null, refAbstract=null), Reference(id=1327672015068181001, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Pediatric Review Committee (PeRC) [EB/OL].(2018-06-15)[2022-07-22].https://www.fda.gov/drugs/development-resources/pediatric-review-committee-perc., articleTitle=null, refAbstract=null), Reference(id=1327672015131095562, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Expedited programs for serious conditions––drugs and biologics [EB/OL].(2020-06-25)[2022-07-22].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/expedited-programs-serious-conditions-drugs-and-biologics., articleTitle=null, refAbstract=null), Reference(id=1327672015194010123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=岳志华,李慧义.中美两国儿童用药安全性监测对比研究[J].中国医药工业杂志,2017,48(6):925-929., articleTitle=null, refAbstract=null), Reference(id=1327672015256924684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Paediatric investigation plans [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/human-regulatory/research-development/paediatric-medicines/paediatric-investigation-plans., articleTitle=null, refAbstract=null), Reference(id=1327672015311450637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Better medicines for children [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/documents/leaflet/better-medicines-children_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672015378559502, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Paediatric Committee(PDCO)[EB/OL].[2022-07-22].https://www.ema.europa.eu/en/committees/paediatric-committee-pdco#:~:text=The%20Paediatric%20Committee%20%28PDCO%29%20is%20the%20European%20Medicines,by%20providing%20scientific%20expertise%20and%20defining%20paediatric%20needs., articleTitle=null, refAbstract=null), Reference(id=1327672015449862671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Needs for Paediatric Medicines [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/human-regulatory/research-development/paediatric-medicines/needs-paediatric-medicines., articleTitle=null, refAbstract=null), Reference(id=1327672015521165840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.European Medicines Agency and European Commission (DG Health and Food Safety) action plan on paediatrics [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/documents/report/european-medicines-agency-european-commission-dg-health-food-safety-action-plan-paediatrics_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672015588274705, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Conduct of pharmacovigilance for medicines used by the paediatric population [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/conduct-pharmacovigilance-medicines-used-paediatric-population., articleTitle=null, refAbstract=null), Reference(id=1327672015655383570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=BLAKE K V, SAINT-RAYMOND A, ZACCARIA C, et al.Enhanced paediatric pharmacovigilance at the european medicines agency: a novel query applied to adverse drug reaction reports [J].Pediatric Drugs, 2016, 18(1): 55-63., articleTitle=null, refAbstract=null), Reference(id=1327672015718298131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=丁锦希,任宏业,蒋蓉.日本临床急需儿童药品政策法规及启示研究[J].现代商贸工业,2016,(13):125-126., articleTitle=null, refAbstract=null), Reference(id=1327672015772824084, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=日本厚生劳动省.药事管理法[EB/OL].(2013-06-14)[2022-07-22].http://roppou.mark-point.jp/条文/薬事法.html., articleTitle=null, refAbstract=null), Reference(id=1327672017467322901, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=PMDA.Enforcement of the ministerial ordinance to partially revise the ministerial ordinance on the criteria for post-marketing surveillance of pharmaceutical products and review of post-marketing surveillance related to reexamination of pharmaceutical products [EB/OL].[2022-07-22].https://www.pmda.go.jp/review-services/inspections/reexam-reeval/0004.html., articleTitle=null, refAbstract=null), Reference(id=1327672017542820374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=陈薇,欧阳昭连,郭文姣,等.日本儿童用药监管策略研究[J].中国药学杂志,2014,49(7):618-621., articleTitle=null, refAbstract=null), Reference(id=1327672017601540631, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=国家卫生计生委,国家发展改革委,工业和信息化部,等.关于保障儿童用药的若干意见[EB/OL].(2014-05-30)[2022-07-22].http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=e51354d631944fa68aac0c4d9585f291., articleTitle=null, refAbstract=null), Reference(id=1327672017677038104, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=佚名.全国药品注册管理和药品上市后监管工作会议[EB/OL].(2022-01-27)[2022-07-22].https://www.nmpa.gov.cn/yaowen/ypjgyw/hyxx/20220127092222164.html., articleTitle=null, refAbstract=null), Reference(id=1327672017744146969, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=佚名.“组合拳”助解儿童用药难题[EB/OL].(2022-06-15)[2022-07-22].https://www.cde.org.cn/main/news/viewInfoCommon/701873e3d25e34d2a460b03a12f90899., articleTitle=null, refAbstract=null), Reference(id=1327672017849004570, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.2021年度药品审评报告[EB/OL].(2022-06-01)[2022-07-22].https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20220601110541120.html., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.11.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.11.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.11.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.11.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1668009600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
药品加快上市程序在儿童用药注册体系中的作用与思考
袁利佳 , 王丽卿 , 汪小燕 , 张宁 *
中国医药工业杂志 | 本期主题:儿童药创新研发与科学监管 2022,53(11): 1529-1538
收起
收藏切换
中国医药工业杂志 |本期主题:儿童药创新研发与科学监管 2022 , 53 (11) : 1529 -1538
药品加快上市程序在儿童用药注册体系中的作用与思考
全屏
[Author(id=1327672011062620642, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672011146506725, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011062620642, language=EN, stringName=Lijia YUAN, firstName=Lijia, middleName=null, lastName=YUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672011213615590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011062620642, language=CN, stringName=袁利佳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

袁利佳(1981—),男,审评项目管理员,从事审评管理工作。

"}, bioImg=null, bioContent=

袁利佳(1981—),男,审评项目管理员,从事审评管理工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672011280724456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672012987806187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011280724456, language=EN, stringName=Liqing WANG, firstName=Liqing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672013067497964, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672011280724456, language=CN, stringName=王丽卿, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672013147189742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672013243658736, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013147189742, language=EN, stringName=Xiaoyan WANG, firstName=Xiaoyan, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672013323350513, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013147189742, language=CN, stringName=汪小燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327672013390459379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangning@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672013470151157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013390459379, language=EN, stringName=Ning ZHANG, firstName=Ning, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672013533065718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, authorId=1327672013390459379, language=CN, stringName=张宁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672010970345950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, xref=null, ext=[AuthorCompanyExt(id=1327672010982928863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327672010991317472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671857307824410, companyId=1327672010970345950, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])]
袁利佳, 王丽卿, 汪小燕, 张宁*
作者信息
  • 国家药品监督管理局药品审评中心,北京 100022
通讯作者:
张宁(1976—),女,高级审评员,从事药品审评工作。E-mail:
作者简介:

袁利佳(1981—),男,审评项目管理员,从事审评管理工作。

The Role and Consideration of Accelerated Approval Process in Pediatric Drug Registration System
Lijia YUAN, Liqing WANG, Xiaoyan WANG, Ning ZHANG*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
出版时间: 2022-11-10 doi: 10.16522/j.cnki.cjph.2022.11.001
文章导航
收藏切换

儿童用药研发困难是全世界面临的难题。由于儿童用药研发难度大、研发成本高、周期长,同时儿童用药服药周期较短,与成人用药的市场相比,市场回报较低,加剧了企业对儿童用药研发不活跃的状况。为了鼓励儿童用药研发,各个国家或地区通过诸多措施鼓励儿童用药的研发。文章对美、欧、日、中等国家及地区为加快儿童用药上市而制定的特殊政策、发布的相关技术指南进行了归纳、汇总并分析,为中国儿童用药研发者及后续的政府法规政策制定提供借鉴及参考。

儿童用药  /  药品注册  /  加快程序

Difficulty in research and development(R&D) of pediatric drugs is a global problem. The high difficulty of R&D, high costs and long cycle of pediatric drugs, as well as the low market returns compared with the adult medicines because of the short medication cycle, aggravate the inactive R&D situation of pediatric drugs. In order to encourage the R&D of pediatric drugs in China, various countries have adopted many measures to acclerate the R&D of pediatric drugs. This paper summarizes and analyzes the special policies and related technical guidelines issued by US, EU, Japan and China to accelerate the review and approval of pediatric drugs, which will serve as a referance for Chinese pediatric drugs developers and the follow-up government regulation and policy makers.

pediatric drug  /  drug regisration  /  accelerated system
袁利佳, 王丽卿, 汪小燕, 张宁. 药品加快上市程序在儿童用药注册体系中的作用与思考. 中国医药工业杂志, 2022 , 53 (11) : 1529 -1538 . DOI: 10.16522/j.cnki.cjph.2022.11.001
Lijia YUAN, Liqing WANG, Xiaoyan WANG, Ning ZHANG. The Role and Consideration of Accelerated Approval Process in Pediatric Drug Registration System[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (11) : 1529 -1538 . DOI: 10.16522/j.cnki.cjph.2022.11.001

参考文献 引证文献
排序方式:
[1]
国家统计局.第七次全国人口普查公报(第五号)—人口年龄构成情况[EB/OL].(2021-05-11)[2022-07-22].http://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202105/t20210511_1817200.html.
[2]
余明莲,杨悦.我国儿童用药可获得性的调查分析[J].解放军药学学报,2011,27(4):368-372.
[3]
龚传欢,杨悦,田丽娟.儿科药物研发激励政策研究[J].中国新药杂志,2022,31(11):1042-1047.
[4]
许淑红,张绮,张林琦,等.探讨我国儿童用药的发展现状及政策层面的思考[J].中国临床药理学杂志,2020,36(12):1760-1767.
[5]
FDA.Pediatric Research Equity Act | PREA [EB/OL].(2019-07-11)[2022-07-22].https://www.fda.gov/drugs/development-resources/pediatric-research-equity-act-prea.
[6]
FDA.Best Pharmaceuticals for Children Act (BPCA) [EB/OL].(2018-09-25)[2022-07-22].https://www.fda.gov/drugs/development-resources/best-pharmaceuticals-children-act-bpca.
[7]
FDA.Pediatric study plans: content of and process for submitting initial pediatric study plans and amended initial pediatric study plans [EB/OL].(2020-08-03)[2022-07-22].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pediatric-study-plans-content-and-process-submitting-initial-pediatric-study-plans-and-amended.
[8]
FDA.Pediatric labeling changes [EB/OL].(2022-08-30)[2022-09-01].https://www.fda.gov/science-research/pediatrics/pediatric-labeling-changes.
[9]
FDA.Food and Drug Administration Moderization Act of 1997[EB/OL].(1997-11-21)[2022-07-22].https://www.congress.gov/105/plaws/publ115/PLAW-105publ115.pdf.
[10]
FDA.List of drugs for which pediatric studies are needed[EB/OL].(2019-04-29)[2022-07-22].https://cacmap.fda.gov/drugs/development-resources/list-drugs-which-pediatric-studies-are-needed.
[11]
FDA.Office of pediatric therapeutics [EB/OL].(2021-10-25)[2022-07-22].https://www.fda.gov/about-fda/office-clinical-policy-and-programs/office-pediatric-therapeutics.
[12]
FDA.Pediatric Advisory Committee [EB/OL].(2022-04-13)[2022-07-22].https://www.fda.gov/advisory-committees/committees-and-meeting-materials/pediatric-advisory-committee.
[13]
FDA.Pediatric Review Committee (PeRC) [EB/OL].(2018-06-15)[2022-07-22].https://www.fda.gov/drugs/development-resources/pediatric-review-committee-perc.
[14]
FDA.Expedited programs for serious conditions––drugs and biologics [EB/OL].(2020-06-25)[2022-07-22].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/expedited-programs-serious-conditions-drugs-and-biologics.
[15]
岳志华,李慧义.中美两国儿童用药安全性监测对比研究[J].中国医药工业杂志,2017,48(6):925-929.
[17]
EMA.Better medicines for children [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/documents/leaflet/better-medicines-children_en.pdf.
[20]
EMA.European Medicines Agency and European Commission (DG Health and Food Safety) action plan on paediatrics [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/documents/report/european-medicines-agency-european-commission-dg-health-food-safety-action-plan-paediatrics_en.pdf.
[21]
EMA.Conduct of pharmacovigilance for medicines used by the paediatric population [EB/OL].[2022-07-22].https://www.ema.europa.eu/en/conduct-pharmacovigilance-medicines-used-paediatric-population.
[22]
BLAKE K V, SAINT-RAYMOND A, ZACCARIA C, et al.Enhanced paediatric pharmacovigilance at the european medicines agency: a novel query applied to adverse drug reaction reports [J].Pediatric Drugs, 2016, 18(1): 55-63.
[23]
丁锦希,任宏业,蒋蓉.日本临床急需儿童药品政策法规及启示研究[J].现代商贸工业,2016,(13):125-126.
[24]
日本厚生劳动省.药事管理法[EB/OL].(2013-06-14)[2022-07-22].http://roppou.mark-point.jp/条文/薬事法.html.
[25]
PMDA.Enforcement of the ministerial ordinance to partially revise the ministerial ordinance on the criteria for post-marketing surveillance of pharmaceutical products and review of post-marketing surveillance related to reexamination of pharmaceutical products [EB/OL].[2022-07-22].https://www.pmda.go.jp/review-services/inspections/reexam-reeval/0004.html.
[26]
陈薇,欧阳昭连,郭文姣,等.日本儿童用药监管策略研究[J].中国药学杂志,2014,49(7):618-621.
[27]
国家卫生计生委,国家发展改革委,工业和信息化部,等.关于保障儿童用药的若干意见[EB/OL].(2014-05-30)[2022-07-22].http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=e51354d631944fa68aac0c4d9585f291.
[28]
佚名.全国药品注册管理和药品上市后监管工作会议[EB/OL].(2022-01-27)[2022-07-22].https://www.nmpa.gov.cn/yaowen/ypjgyw/hyxx/20220127092222164.html.
[29]
佚名.“组合拳”助解儿童用药难题[EB/OL].(2022-06-15)[2022-07-22].https://www.cde.org.cn/main/news/viewInfoCommon/701873e3d25e34d2a460b03a12f90899.
[30]
国家药品监督管理局.2021年度药品审评报告[EB/OL].(2022-06-01)[2022-07-22].https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20220601110541120.html.
2022年第53卷第11期
72
15
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.11.001
  • 接收时间:2022-07-22
  • 首发时间:2026-11-12
  • 出版时间:2022-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-07-22
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100022

通讯作者:

张宁(1976—),女,高级审评员,从事药品审评工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.11.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏